Doctors at Mayo Clinic actively research the use of endoscopic ultrasound in pancreatic disease, lung cancer and esophageal cancer. These research activities include:

  • The role of endoscopic ultrasound in lung cancer staging
  • Genomic detection of micrometastases in mediastinal lymph nodes in people who have lung cancer
  • Endoscopic ultrasound and secretin-stimulated pancreatic juice for cytokines in the evaluation of chronic pancreatitis, pancreatic cancer and cystic neoplasms
  • Genomic array evaluation of esophageal cancer before and after chemo-radiotherapy
  • Genomic and proteomic evaluation of cyst fluid in pancreatic cystic neoplasms
  • Ablation of pre-cancer pancreatic cysts with endoscopic ultrasound-guided ethanol injection
  • Using endoscopic ultrasound and ultrasound within the airway (endobronchial) to detect cancerous lymph nodes in the central chest (mediastinum)
  • Using endoscopic ultrasound, fine-needle aspiration and molecular diagnostic methods (real-time polymerase chain reaction) to detect microscopic cancer deposits in otherwise normal-appearing mediastinal lymph nodes
  • Detecting pancreatitis and pancreatic cancer with endoscopic ultrasound and endoscopic collection of pancreatic juice after stimulation with secretin
  • Detecting precancerous cystic lesions of the pancreas using fine-needle aspiration and protein analysis (proteomics) of cyst fluid
  • Improved control of pancreatic cancer pain with endoscopic ultrasound-guided celiac plexus neurolysis

See a list of Mayo Clinic publications at PubMed, a service of the National Library of Medicine.